The Ink4/Arf locus is a barrier for iPS cell reprogramming H Li, M Collado, A Villasante, K Strati, S Ortega, M Cañamero, MA Blasco, ... Nature 460 (7259), 1136-1139, 2009 | 1134 | 2009 |
miR-181b negatively regulates activation-induced cytidine deaminase in B cells VG De Yébenes, L Belver, DG Pisano, S Gonzalez, A Villasante, C Croce, ... The Journal of experimental medicine 205 (10), 2199-2206, 2008 | 304 | 2008 |
Cardiac recovery via extended cell-free delivery of extracellular vesicles secreted by cardiomyocytes derived from induced pluripotent stem cells B Liu, BW Lee, K Nakanishi, A Villasante, R Williamson, J Metz, J Kim, ... Nature biomedical engineering 2 (5), 293-303, 2018 | 296 | 2018 |
p27Kip1 directly represses Sox2 during embryonic stem cell differentiation H Li, M Collado, A Villasante, A Matheu, CJ Lynch, M Cañamero, ... Cell stem cell 11 (6), 845-852, 2012 | 191 | 2012 |
Tissue-engineered models of human tumors for cancer research A Villasante, G Vunjak-Novakovic Expert opinion on drug discovery 10 (3), 257-268, 2015 | 110 | 2015 |
Stem cell delivery in tissue-specific hydrogel enabled meniscal repair in an orthotopic rat model X Yuan, Y Wei, A Villasante, JJD Ng, DE Arkonac, PG Chao, ... Biomaterials 132, 59-71, 2017 | 92 | 2017 |
Bioengineered human tumor within a bone niche A Villasante, A Marturano-Kruik, G Vunjak-Novakovic Biomaterials 35 (22), 5785-5794, 2014 | 83 | 2014 |
Recapitulating the Size and Cargo of Tumor Exosomes in a Tissue-Engineered Model A Villasante, A Marturano-Kruik, SR Ambati, Z Liu, A Godier-Furnemont, ... Theranostics 6 (8), 1119-1130, 2016 | 82 | 2016 |
Epigenetic regulation of Nanog expression by Ezh2 in pluripotent stem cells A Villasante, D Piazzolla, H Li, G Gomez-Lopez, M Djabali, M Serrano Cell Cycle 10 (9), 1488-1498, 2011 | 60 | 2011 |
Biomechanical regulation of drug sensitivity in an engineered model of human tumor A Marturano-Kruik, A Villasante, K Yaeger, SR Ambati, A Chramiec, ... Biomaterials 150, 150-161, 2018 | 53 | 2018 |
Galvanic microparticles increase migration of human dermal fibroblasts in a wound-healing model via reactive oxygen species pathway N Tandon, E Cimetta, A Villasante, N Kupferstein, MD Southall, A Fassih, ... Experimental cell research 320 (1), 79-91, 2014 | 33 | 2014 |
Osteosarcoma tissue-engineered model challenges oxidative stress therapy revealing promoted cancer stem cell properties J Tornín, A Villasante, X Solé-Martí, MP Ginebra, C Canal Free Radical Biology and Medicine 164, 107-118, 2021 | 31 | 2021 |
Biomimetic tissue–engineered systems for advancing cancer research: NCI strategic workshop report TK Schuessler, XY Chan, HJ Chen, K Ji, KM Park, A Roshan-Ghias, ... Cancer research 74 (19), 5359-5363, 2014 | 28 | 2014 |
Tissue-engineered model of human osteolytic bone tumor A Villasante, A Marturano-Kruik, ST Robinson, Z Liu, XE Guo, ... Tissue Engineering Part C: Methods 23 (2), 98-107, 2017 | 26 | 2017 |
Vascularized tissue-engineered model for studying drug resistance in neuroblastoma A Villasante, K Sakaguchi, J Kim, NK Cheung, M Nakayama, H Parsa, ... Theranostics 7 (17), 4099, 2017 | 22 | 2017 |
Bioengineered models of solid human tumors for cancer research A Marturano-Kruik, A Villasante, G Vunjak-Novakovic Bioreactors in Stem Cell Biology: Methods and Protocols, 203-211, 2016 | 15 | 2016 |
Bioengineered tumors A Villasante, G Vunjak-Novakovic Bioengineered 6 (2), 73-76, 2015 | 10 | 2015 |
Horizontal transfer of the stemness-related markers EZH2 and GLI1 by neuroblastoma-derived extracellular vesicles in stromal cells A Villasante, A Godier-Furnemont, A Hernandez-Barranco, J Le Coq, ... Translational Research 237, 82-97, 2021 | 9 | 2021 |
Mutational mechanisms of EZH2 inactivation in myeloid neoplasms A Chase, J Score, F Lin, C Bryant, K Waghorn, S Yapp, ... Leukemia 34 (12), 3206-3214, 2020 | 9 | 2020 |
Mimicking biophysical stimuli within bone tumor microenvironment A Marturano-Kruik, K Yeager, D Bach, A Villasante, E Cimetta, ... 2015 37th Annual International Conference of the IEEE Engineering in …, 2015 | 8 | 2015 |